Australian Government - Austrade


Go to international website
Search Click to start search
Username   Password  Remember me Click to Login
Join  Forgotten Password?  Contact Us 
You are here:
Thailand

Health and medical to Thailand

Click to send this to a friendClick to print pageClick to print page to PDFContact usChange to standard fontChange to large font

(Last updated: 6 Nov 2008)

Trends and opportunities

The market

The Ministry of Health is responsible for management of healthcare services in the public sector. Responsibilities are divided between the central and provincial administration. Each region has a Regional General Hospital that has a capacity of 500-1000 beds. Each province has a Provincial General Hospital and a Provincial Health Office. Each district also has a District Health Office. At village level, health centres provide healthcare services.


The healthcare sector comprises around 1360 hospitals, of which about two-thirds are in the public sector. In 2006 Thailand had an estimated 145,000 hospital beds, with 40,000 of these in the private sector.


The public sector hospitals provide good coverage at various levels. At the provincial level the country has coverage of 100 per cent with a 90.6 per cent coverage at district level. 

The Ministry of Public Health (MOPH) is the largest agency operating in two-thirds of all hospitals and beds across the country. Approximately, 67 per cent of hospitals and 64 per cent of beds belong to the MOPH. Of all public sector hospitals, over 80 per cent are community hospitals in various districts, and only 5.5 per cent of the hospitals belong to other ministries.


There has been an increase in the number of private hospitals in the past few years. In 2006 there were 471 private hospitals, most of which were concentrated in urban areas and 44 per cent of private hospitals being located in Bangkok. Most private hospitals now have occupancy rates of only around 30 per cent, as more Thais covered by the government scheme opt for treatment under the Bt30 scheme.


The Bt30 medical care program


The Bt30 medical care program was launched in April 2001. It is a national healthcare scheme that is affordable to all. All kinds of medical care provided at public hospitals will be conducted under Bt30. The main factor is the reduction in medical costs and the maximisation of the health budget for the benefit of poor people.


The annual medical cost per head stands at Bt1396, but the new health program means that for Bt30 per session, Thais can obtain treatment for diseases.


More than 47 million Thai consumers have registered for this health program, and more than 160,000 have been given high cost treatments. For example, more than 7000 patients have received brain operations, more than 5500 have been treated for heart disease, and over 46,000 cancer patients have been treated.


The National Economic and Social Development Board in Thailand found that 77 per cent of the Thai population is pleased with this program, especially those in low-income groups. However, a negative aspect of the program is that medical staff – doctors, nurses and pharmacists – are overworked. Hospitals, particularly those in rural areas, suffer from high expenses and operate at a loss.


The Ministry of Public Health cooperates with other government ministries with the aim of making Thailand the centre for health services in Asia by 2010. The target is to increase the number of foreigners seeking medical treatment in Thailand’s hospitals from a total of 970,000 in 2003 to two million by 2010. As Thailand’s cost of living is much lower than in Japan, the US and Europe, it is much cheaper for foreigners to obtain medical care in Thailand than in their own countries.


The government has introduced a plan to run over the 2004-2009 period to turn Thailand into a medical services hub for Asia, and has set aside more than Bt2.6 billion to make Thailand Asia’s centre of healthcare excellence.


Apart from the provision of medical services, the plan places an emphasis on spa and traditional massage services. The plan envisages that revenue of Bt200 billon will be generated in the next five years. Of this, two-thirds is expected to come from medical services, Bt50 billion from the spa business and Bt20 billion from health products.


The Ministry of Commerce is considering shortening the waiting time for visas for people who want to come to Thailand for treatment, and has been encouraging the state hospitals to get involved by offering foreign-language courses to staff. Private hospitals have also started offering non-medical services, such as booking flights and arranging visas for patients. In addition, the government is backing a Hospital Accreditation (HA) scheme, whereby a hospital is accredited if it reaches international standards. The government is targeting a total of 1170 hospitals by the end of 2009.


Pharmaceuticals


Thailand has a well-developed and dynamic pharmaceutical sector, but it too has been critical of the universal healthcare program. Manufacturers complain that they are being forced to cut profit margins because of the health systems funding crisis, and foreign manufacturers have said that since the introduction of the scheme the demand for premium products has fallen.


Growth in the overall market, however, has remained strong. The local pharmaceutical sector is already fully liberalised, with no limits on foreign entrants to the market.


The Thai pharmaceutical market is divided roughly in half between prescribed and over-the-counter (OTC) drugs. The prescription sector, which accounted for 56 per cent of the market, includes all drugs prescribed by a doctor and distributed by hospitals and chemists. The OTC market includes common household remedies and a few medicines that are also prescribed. It is estimated that as much as 60 per cent of the population’s health expenditure goes directly to drugs.


Medical equipment and supplies


Thailand’s market for medical equipment and supplies grew by an estimated 23 per cent in 2005 and is expected to maintain steady growth of 20 per cent in 2007. About 87 per cent of products used in this sector are imported. The growth is expected mainly from healthcare facility expansion and medical equipment replacement and upgrades.


Thailand relies on the import of medical devices, especially sophisticated, higher-end devices. Local production of medical devices in Thailand is reduced to less sophisticated devices, mainly due to the limited number of qualified researchers and limited capability to invest in the R&D required to produce more sophisticated devices.


Locally-produced products include reagents, simple disposable test kits, disposable syringes, artificial legs and other orthopedic accessories, and other simple disposable items.


Wellbeing, vitamins and dietary supplements


Despite political turmoil, demand for vitamins and dietary supplements grew strongly in 2007.


Thai consumers are aware of beauty, good health, and mental and physical development. These are the major drivers of growing demand for bone health and beauty dietary supplements. The trend of healthy lifestyle and beauty concerns is expected to grow.


The expansion and growing popularity for supermarkets, hypermarkets and convenience stores contributed to stronger sales of vitamins and dietary supplements in grocery retailers.

  

Opportunities

Thailand relies on the import of medical devices, especially sophisticated, higher-end devices. Public hospitals are still major users and buyers of medical devices and supplies in Thailand. They account for approximately 60 per cent of total purchases.


Other areas of opportunities include:

  • Diagnostic kits for tropical diseases
  • Multi-vitamins and supplements with key benefits related to bone and joint health or beauty
  • Hospital information systems
back to top of site

Tariffs, regulations and customs

The importation of medical devices is controlled by the Thai Food and Drug Administration (FDA) and prior approval of imports is required.


The Thai FDA will accept medical devices that pass the following standards:

  • U.S. Food and Drug Administration (USFDA) - USA
  • CE Mark - Europe
  • Pharmaceutical Affair Bureau (PAB) - Japan
  • Therapeutic Good Administration (TGA) - Australia
  • State Bureau of  Pharmaceutical Administration of China (SPAC) - China

All manufacturers and importers of pharmaceutical products have to obtain a certificate of registration before a drug can be sold.


The Government Pharmaceutical Organisation (GPO) is responsible for regulating pharmaceutical prices and quality controls. The GPO also produces generic drugs, and the government undertakes trading of pharmaceutical products through the GPO.

The import tariff for health supplement products is 30 per cent. According to the Thailand-Australia Free Trade Agreement, the Thai Government may abolish import duties for some vitamins and its derivatives to zero per cent.


There are currently no import restrictions or import quotas on health supplement products in Thailand although an import license must obtained by the Food and Drug Administration (FDA).


The FDA requires the labelling of products to be in the Thai language.


The Therapeutic Goods of Australia provides more information on the export of medicines from Australia.


In addition, the Free Trade Agreement (FTA) between Australia and Thailand, finalised in 2004, ensure greater access for Australian products and improve prospects for services and trade investment. It also eliminates most of Thailand’s tariff and quota barriers on imports from Australia.

back to top of site

Marketing your products and services

Market entry

Use of local agents or distributors is highly recommended for marketing medical devices in Thailand. The agent provides immediate access to an established marketing network and in-depth knowledge about pertinent regulations.


Buyers and end-users expect a local representative to handle after-sales service and stock spare parts. The agent also should be expected to develop close personal relationships with the buyers and end-users, an important factor in future procurement decisions.

Distribution channels

Direct sale is still a major distribution channel whereas Internet is an advertising channel since consumers tend to use the Internet to research products online and seek information.

back to top of site

Links and industry contacts

Health–related resources

Therapeutic Goods of Australia – www.health.gov.au/tga/docs/html/export/export.htm

Food and Drug Administration – www.fda.moph.go.th/enginfo.htm

Pharmaceutical Producers Association – www.ppathai.org


Thai Pharmaceutical Manufacturers Association
Tel: +662 433 6547 or 424 8588

Government, business and trade resources for Thailand

Ministry of Commerce – www.moc.go.th
Ministry of Foreign Affairs – www.mfa.go.th
Royal Thai Customs Department – www.customs.go.th
Stock Exchange of Thailand – www.set.or.th/en/index.html
Thai Chamber of Commerce – www.tcc.or.th
Thailand Board of Investment – www.boi.go.th
Tourism Authority of Thailand – www.tourismthailand.org
World Trade Organization – www.wto.org
Yellow Pages – www.yellowpages.co.th

Media

The Bangkok Post – www.bangkokpost.com
The Nation – www.nationmultimedia.com
Thailand.com – www.thailand.com 
Bangkok.com – www.bangkok.com

Australian resources

Australian Embassy Bangkok – www.austembassy.or.th
Australian-Thai Chamber of Commerce – www.austchamthailand.com

Service providers

Qantas freight – www.qantas.com.au/freight/dyn/menu
British Airways Air Cargo – www.baworldcargo.com
Airports of Thailand PLC – www.airportthai.co.th
Thai Airways International – www.thaiairways.com 


Thai International Freight Forwarders Association
Email: ifffa@a-net.net.th

back to top of site

Contact details

The Australian Trade Commission (Austrade) is the Australian Government’s trade and investment development agency, operating as a statutory agency within the Foreign Affairs and Trade portfolio.

Austrade assists Australian businesses contribute to national prosperity by succeeding in trade and investment, internationally, and promoting and supporting productive foreign investment into Australia.

Austrade:

  • Delivers services that assist Australian businesses initiate, sustain and grow trade and outward investment.
  • Promotes Australia as an inward investment destination and, with the States and Territories, supports the inflow of productive foreign direct investment.
  • Administers the Export Market Development Grants scheme.
  • Undertakes initiatives designed to improve community awareness of, and commitment to, international trade and investment.
  • Provides advice to the Australian Government on its trade and investment development activities.
  • Delivers consular, passport and other government services in designated overseas locations.

A list of Austrade offices (in alphabetical order of country) is available.

More information

For further information please contact Austrade on 13 28 78 or email info@austrade.gov.au

back to top of site

Share this content

Sidebar Content

Export Update

Austrade's monthly eNewsletter bringing you all the latest export-related news and events within Australia and overseas.

Export Opportunities

Register on the online database - a useful tool in identifying international business leads to support your firm’s export strategy.

Case studies

Austrade has profiled over  100 companies from a range of industries and markets, all over Australia. Read these case studies.

     

Footer Information

Economist's Corner | Publications | Student Centre | Employment | DFAT | Minister for Trade | Contact Us | RSS/XML Feeds
Privacy Disclaimer | Technical Info | Site Disclaimer | Linking Policy | Site Map | Useful Websites | FAQs | Blogs

Disclaimer

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.